Faizi A. Jamal, M.D.
Driven by his compassion for those fighting cancer and devotion to precision, Faizi Jamal, M.D., is committed to providing the most optimal cardiovascular care for his patients. Before joining City of Hope, Dr. Jamal worked for five years at the Northwestern University Feinberg School of Medicine in Chicago. He received his medical degree from the University of California Irvine's School of Medicine and completed his residency and fellowship at Cedars-Sinai Medical Center in Los Angeles.
Dr. Jamal specializes in cardiovascular disease and cardiac imaging, and is an expert in managing heart failure, including cardiomyopathy associated with rare conditions such as cardiac amyloidosis and cardiovascular complications resulting from esoteric immunotherapies.
During his time at City of Hope, Dr. Jamal has brought about multiple advancements in the techniques used to visualize the heart's structure and function. His research focuses on earlier detection of cardiotoxicity and applying artificial intelligence algorithms to measure cardiac function.
Location
Duarte Cancer Center
Duarte, CA 91010
Education & Experience
Cardiovascular Disease, American Board of Internal Medicine
Adult Comprehensive Echocardiography, National Board of Echocardiography
Nuclear Cardiology, Certification Board of Nuclear Cardiology
Internal Medicine, American Board of Internal Medicine
2003, M.D., University of California Irvine School of Medicine, Irvine, California
1999, B.S. in Biology, cum laude, Regents Scholar, University of California Riverside, Riverside, California
2007-2010, Cardiovascular Disease, Cedars-Sinai Medical Center, Los Angeles, CA
2003-2006, Internal Medicine Program, Cedars-Sinai Medical Center, Los Angeles, CA
2022-present, Associate Clinical Professor, Division of Cardiology, Department of Medicine, City of Hope, Duarte, CA
2021-present, Chief, Division of Cardiology, Department of Medicine, City of Hope, Duarte, CA
2021-present, Director, Non-Invasive Cardiology Laboratory, Department of Medicine, City of Hope, Duarte, CA
2017-2022, Assistant Clinical Professor, Division of Cardiology, Department of Medicine, City of Hope, Duarte, CA
2012-2017, Attending Cardiologist and Clinical Instructor of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
2010-2012, Noninvasive Cardiologist, Southwest Medical Associates, A subsidiary of UnitedHealth Group, Las Vegas, Nevada
2006-2007, EP Hospitalist, Division of Cardiac Electrophysiology, Department of Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California
Publications
Manuscripts
- Jamal F, Rosenzweig M. Amyloidosis with cardiac involvement: identification, characterization and management. Current Hematologic Malignancy Reports (Manuscript submitted for publication.)
- Jamal F, Khaled S. The cardiovascular complications of chimeric antigen receptor T cell therapy. Current Hematologic Malignancy Reports. 2020 Feb 3. https://doi.org/10.1007/s11899-020-00567-4
- Gupta R, Jamal F, Yang D, Chendri C, Aldoss I, Malki M, Mei M, Salhotra A, Dobrin S, Tran M, Venkataraman K, Palmer J, Stein A, Sandhu K, Khaled S, Aribi A, Marcucci G, Forman S, Snyder D, Nakamura R, Ali H, Pullarkat V. Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosis. Bone Marrow Transplantation. 2019 November 6; doi: 10.1038/s41409-019-0741-8.
- Lee MS, Jamal F, Kapoor N, Forrester J, Jalisi N, Czer L, Mirocha J, Kar S, Kedia G, Chang G, Zimmer R, DeRobertis M, Trento A, Fontana G, Shah PK, Makkar RR. Comparison of Bypass Surgery with Drug-Eluting Stents for Diabetic Patients with Multivessel Disease. International Journal of Cardiology 2007 December 15; 123(1): 34-42
- Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, Kar S, Dohad S, Kass R, Eigler N, Trento A, Shah PK, Makkar RR. Comparison of Coronary Artery Bypass Surgery with Percutaneous Coronary Intervention with Drug-Eluting Stents for Unprotected Left Main Coronary Artery Disease. Journal of the American College of Cardiology 2006 February; 47(4): 864-870
- Lee MS, Shah AP, Dang N, Berman D, Forrester J, Shah PK, Aragon J, Jamal F, Makkar RR. The Coronary Sinus is Dilated and Outwardly Displaced in Patients with Mitral Regurgitation: Quantitative Angiographic Analysis. Catheterization and Cardiovascular Interventions 2006 March; 67(3): 490-494
- Khan AM, Curras MC, Dao J, Jamal FA, Turkowski CA, Goel RK, Gillard ER, Wolfsohn SD, Stanley BG. Lateral hypothalamic NMDA receptor subunits NR2A and/or NR2B mediate eating: immunochemical/behavioral evidence. American Journal of Physiology. 1999 March; 276(3 Pt 2): R880-91
Abstracts
- Gupta R, Jamal F, Yang D, Ali H, Aldoss I, Malki M, Mei M, Salhotra A, Dobrin S, Tran M, Venkataraman K, Palmer J, Stein A, Sandhu K, Khaled S, Aribi A, Marcucci G, Forman S, Snyder D, Nakamura R, Pullarkat V. Pulmonary arterial hypertension (PAH) is associated with increased non-relapse mortality after allogeneic hematopoietic cell transplantation (alloHCT) for myelofibrosis. Biology of Blood and Marrow Transplantation 2019 March; 25(3) supplement: S121
- Jamal F, Lim S, Vescio R, Pepkowitz S, VanStrien P, Hoshal K, Lill MC. Myeloablative chemotherapy and autologous peripheral stem cell transplantation without the use of blood products. Biology of Blood and Marrow Transplantation 2005 February; 11(2) supplement 1: 66-67
- Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, Kar S, Dohad S, Kass R, Eigler N, Trento A, Shah PK, Makkar RR. Comparison of Coronary Artery Bypass Surgery with Percutaneous Coronary Intervention with Drug-Eluting Stents for Unprotected Left Main Coronary Artery Disease. American Journal of Cardiology 2005; 96(Suppl): 517
- Khan AM, Stanley BG, Jamal FA, Goel RK, Dao J, Gillard ER, Curras MC. 2B or not 2B: Behavioral, biochemical and immunocytochemical evidence for the involvement of the NR2B NMDA receptor subunit in lateral hypothalamic (LH) feeding. Society for Neuroscience Abstracts, v. 23, n. 1-2, (1997.): 576